Controlled trial of inhaled fluticasone propionate in moderate to severe COPD

Lung

Volumn 180, Issue 4, 2002, Pages 191-201

  Thompson, William H ^a,b   Carvalho, P ^a,b   Souza, J P ^a,b   Charan, N B ^a,b  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Boise VA Medical Center   (United States)

Author keywords

COPD; Fluticasone propionate; Inhalers; Pulmonary function tests

Indexed keywords

BRONCHODILATING AGENT; CORTICOSTEROID; FLUTICASONE PROPIONATE; IPRATROPIUM BROMIDE; SALBUTAMOL;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MECHANISM; DYSPHONIA; DYSPNEA; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; METERED DOSE INHALER; OUTPATIENT; OXYGEN TENSION; PRIORITY JOURNAL; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SOLDIER; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; URTICARIA;

ACUTE DISEASE; ADMINISTRATION, INHALATION; ADRENOCORTICOTROPIC HORMONE; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; ANDROSTADIENES; ANTI-INFLAMMATORY AGENTS; BLOOD GAS ANALYSIS; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; FORCED EXPIRATORY VOLUME; HUMANS; IDAHO; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATORY FUNCTION TESTS; SEVERITY OF ILLNESS INDEX; SMOKING; TREATMENT OUTCOME; VITAL CAPACITY;

EID: 0036460706     PISSN: 03412040     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004080000093     Document Type: Article

References (24)

1. Albert RK, Martin TR, Lewis SW (1980) Controlled clinical trial of methylprednisolone in patients with chronic bronchitis and acute respiratory insufficiency. Ann Intern Med 92:753-758
2. American Thoracic Society (1987) Standardization of spirometry - 1987 Update. Am Rev Respir Dis 136:1285-1298
3. American Thoracic Society (1995) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 152:S77-S120
4. 1. JAMA 272:1497-1505
5. Bourbeau J, Rouleau MY, Boucher S (1998) Randomized controlled trial of inhaled corticosteroids in patients with chronic obstructive pulmonary disease. Thorax 53:447-482
6. Burge PS, Calverley PMA, Jones PW, Spencer S, Anderson JA, Maslen TK (2000) Randomized, double-blind, placebo-controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: The ISOLDE trial. BMJ 320:1297-1303
7. Calverley PMA, Barnes PJ (2000) Pro/Con Editorials. Am J Respir Crit Care Med 161:341-344
8. Davies L, Nisar M, Pearson MG, Costello RW, Earis JE, Calverley PME (1999) Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease. Q J Med 92:395-400
9. Dompeling E, van Schayck CP, van Grunsven PM, van Herwaarden CLA, Akkermans R, Molema J, Folgering H, van Weel C (1993) Slowing the deterioration of asthma and chronic obstructive pulmonary disease observed during bronchodilator therapy by adding inhaled corticosteroids. Ann Int Med 118:770-778
10. Guyatt GH, Herman LB, Townsend M, Pugsley SO, Chambers LW (1987) A measure of quality of life for clinical trials in chronic lung disease. Thorax 42:773-778
11. Hudson LD, Monti CM (1990) Rationale and use of corticosteroids in chronic obstructive pulmonary disease. Med Clin N Am 74:661-690
12. Kamada AK, Szefler SJ, Martin RJ, Boushey HA, Chinchilli VM, Drazen JM, Fish JE, Israel E, Lazarus SC, Lemanske RF (1996) Issues in the use of inhaled glucocorticoids. Am J Respir Crit Care Med 153:1739-1748
13. Kerstjens HAM, Brand PLP, Hughes MD, Robinson NJ, Postma DS, Slutter H J, Bleecker ER, Dekhuijzen PNR, de Jong PM, Mengelers JJ, Overbeek SE, Schoonbrood DFME (1992) A comparison of bronchodilator therapy with or without inhaled corticosteroid therapy for obstructive airways disease. N Engl J Med 327:1413-1419
14. The Lung Health Study Research Group (2000) Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 343:1902-1909
15. Niewoehner DE, Erbland ML, Deupree RH, Collins D, Gross NJ, Light RW, Anderson P, Morgan NA (1999) Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. N Engl J Med 340:1941-1947
16. Paggiaro PL, Dahle R, Bakran I, Frith L, Hollingworth K, Efthimiou J (1998) Multicenter randomized placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease. Lancet 351:773-780
17. Pauwels RA, Lofdahl CG, Laitinen LA, Schouten JP, Postma DS, Pride NB, Ohlsson SV (1999) Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. N Engl J Med 340:1948-1953
18. Renkema TEJ, Schouten JP, Koeter GH, Postma DS (1996) Effects of long-term treatment with corticosteroids in COPD. Chest 109:1156-1162
19. Thaler LM, Blevins LS (1998) The low dose (1 μg) adrenocorticotropin stimulation test in the evaluation of patients with suspected central adrenal insufficiency. J Clin Endocrinol Metab 83:2726-2729
20. Thompson WH, Nielson CP, Carvalho P, Charan NB, Crowley JJ (1996) Controlled trial of oral prednisone in outpatients with acute COPD exacerbation. Am J Respir Crit Care Med 154:407-412
21. VanAndel AE, Reisner C, Menjoge SS, Witek TJ (1999) Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest 115:703-707
22. Vestbo J, Sorensen T, Lange P, Brix A, Torre P, Wiskum K (1999) Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: A randomized controlled trial. Lancet 353:1819-1823
23. Weir DC, Bale GA, Bright P, Burge PS (1999) A double-blind placebo-controlled study of the effect of inhaled beclomethasone dipropionate for 2 years in patients with nonasthmatic chronic obstructive pulmonary disease. Clin Exp Allergy 29:S125-S128
24. Wise RA (1997) Changing smoking patterns and mortality from chronic obstructive pulmonary disease. Prev Med 26:418-421